Pilocytic astrocytoma in the elderly
K Burkhardt1, F Heuberger, J Delavelle
1Department of Surgical Pathology, University Hospitals of Geneva, Geneva, Switzerland. Karim.Burkhardt@hcuge.ch
Clinical Neuropathology
|February 1, 2008
Summary
Pilocytic astrocytoma, a rare brain tumor in the elderly, was found in an 85-year-old man presenting with Parkinsonism. This case highlights the importance of considering unusual diagnoses in older patients with neurological symptoms.
Area of Science:
- Neuropathology
- Neuro-oncology
- Geriatric Neurology
Background:
- Pilocytic astrocytoma (WHO Grade 1) is a common pediatric low-grade glioma with an excellent prognosis.
- Diagnosis in elderly patients is exceptionally rare, with limited literature available.
- Neurological presentations in the elderly can be diverse and mimic other conditions.
Observation:
- An 85-year-old male presented with neurological signs suggestive of Parkinsonism.
- Post-mortem examination revealed a pilocytic astrocytoma located in the brainstem.
- This represents a highly unusual occurrence of this specific glioma in an advanced age group.
Findings:
- The pilocytic astrocytoma in this elderly patient was confirmed neuropathologically.
- The tumor's presence in the brainstem contributed to the observed Parkinsonian symptoms.
- Differential diagnostic considerations for brainstem lesions and Parkinsonism are discussed.
Implications:
- This case underscores the need to consider rare diagnoses, including pilocytic astrocytoma, in the differential diagnosis of neurological disorders in the elderly.
- It highlights the importance of thorough post-mortem examination for identifying unexpected pathologies.
- Further research may be warranted to understand the potential for pilocytic astrocytoma development or presentation in older individuals.
Related Concept Videos
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...